Dow Down 0.15% Nasdaq Down 0.23%

Myriad Genetics, Inc. (MYGN)

-NasdaqGS
34.26 Up 0.32(0.94%) 3:19PM EDT - Nasdaq Real Time Price
Prev Close:33.94
Open:33.98
Bid:34.01 x 200
Ask:34.03 x 400
1y Target Est:39.58
Beta:0.216621
Next Earnings Date:N/A
Day's Range:33.85 - 34.82
52wk Range:30.30 - 46.24
Volume:809,373
Avg Vol (3m):925,408
Market Cap:2.44B
P/E (ttm):25.76
EPS (ttm):1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MYGN

Comparison

Symbol% ChgMkt Cap
MYGNUp 0.94%2.44B
ABTUp 0.89%56.49B

Key Statistics

Forward P/E (1 yr):19.01
P/S (ttm):3.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :1.65
Quarterly EPS Est (Jun-16) :0.38
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.41

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a personalized medicine company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback